David R Epstein Seagen Inc. (SGEN) insider trading activity

SGEN Quotes by TradingView

David R Epstein is CEO of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 16,407 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $3,757,203. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

David R Epstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$3,757,203 $229.0 p/Share
16,407 Reduced 100.0%
0 Common Stock
Nov 10 2023
SELL
Open market or private sale
$2,262,166 $213.01 p/Share
10,620 Reduced 7.21%
136,598 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
39,650 Added 21.22%
147,218 Common Stock
Nov 09 2022
BUY
Grant, award, or other acquisition
-
107,389 Added 50.0%
107,389 Common Stock

Also insider at

EVLO
Evelo Biosciences, Inc. Healthcare
Director
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
Director
RUBY
Rubius Therapeutics, Inc. Healthcare
Director
AXLA
Axcella Health Inc. Healthcare
Director
SNTI
Senti Biosciences, Inc. Healthcare
Director
TEM
Tempus AI, Inc.
DRE

David R Epstein

CEO
South San Francisco, CA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGEN